MIRA INFORM REPORT

 

 

Report No. :

330552

Report Date :

13.07.2015

 

IDENTIFICATION DETAILS

 

Name :

NEOSPAN PHARMA CARE PRIVATE LIMITED

 

 

Registered Office :

Old No. 2, New No. 5, Sowarashtra Nagar, III Street, Choolaimedu, Chennai – 600094, Tamilnadu

Tel. No.:

91-44-42657117

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

21.04.2008

 

 

Com. Reg. No.:

18-067423

 

 

Capital Investment / Paid-up Capital :

Rs. 0.100 Million

 

 

CIN No.:

[Company Identification No.]

U5139TN2008PTC067423

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHEN07032E

 

 

PAN No.:

[Permanent Account No.]

AACCN7904P

 

 

TNVAT No.:

33021483453

 

 

CST No.:

873325

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Pharma Products.

 

 

No. of Employees :

5 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (28)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject established as a partnership firm in the year 2004 with the name of span pharma and firm was reconstituted as a private limited company in the year 2008 with the name of “NEOSPAN PHARMA CARE PRIVATE LIMITED”. It is an established company having moderate track record.

 

For the financial year ended 2014, company possesses below average operational performance and reported dip in its sales turnover profile, which led to dip in profit of the company during a year under a review.

 

Rating further constrained on account of company’s moderate financial risk profile marked by negative reserves and leverage balance sheet of the company.

 

Moreover, rating also takes into account small scale of business operations in intensely competitive pharma trading business.

 

However, management has reported an above average operational performance along with profit during FY 2015 which led to recover accumulated losses, as per its provisional financial statement which could be not verified and are provided for your mere reference.

 

Trade relations are reported as fair. Payments are reported to be slow but correct.

 

In view of moderate business profile along with leverage balance sheet position, the company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

 

INFORMATION PARTED BY

 

Name :

Mr. Antony Francies

Designation :

Director

Date :

06.07.2015

 

 

LOCATIONS

 

Registered Office :

Old No. 2, New No. 5, Sowarashtra Nagar, III Street, Choolaimedu, Chennai – 600094, Tamilnadu, India

Tel. No.:

91-44-42657117

Fax No.:

Not Available

E-Mail :

neospanpharma@gmail.com

Area :

220 sq. ft.

Location :

Rented

 

 

DIRECTORS

 

AS ON 28.03.2013

 

Name :

Mr. Antony Charles Siluvai Francies

Designation :

Director

Address :

Plot No-V, Moorthy Nagar, 3rd Street, Chettiyar Agaram, Chennai – 600077, Tamilnadu, India

Date of Birth/Age :

12.03.1966

Qualification :

B.Sc.

Date of Appointment :

21.04.2008

DIN No.:

02066193

Experience :

13 Years

PAN No.:

AAEPC5210E

 

 

Name :

Mrs. Neola Jancy

Designation :

Director

Address :

Plot No-V, Moorthy Nagar, 3rd Street, Chettiyar Agaram, Chennai – 600077, Tamilnadu, India

Date of Birth/Age :

14.03.1968

Qualification :

B.Sc

Date of Appointment :

21.04.2008

DIN No.:

02093644

Experience :

7 Years

PAN No.:

AFCPN9047B

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 28.03.2013

 

Names of Shareholders

No. of Shares

% of Holding

Antony Charles Siluvai Francies

2500

25.00

T. Newman Fernando

2500

25.00

C. Latha Newman

2500

25.00

Neola Jancy

2500

25.00

Total

10000

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Pharma Products.

 

 

Products :

Not Divulged

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Cash and Credit (30/90 days)

 

 

Purchasing :

Credit (30 days)

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Biosquare Life Science – 3/3, Kumaran Nagar, Seevaram 1st, Perungudi, Chennai – 600096, Tamilnadu, India

Name of the Person :

Mr. Jegan (Manager)

Contact No.:

91-8220659666

Since How Long Known :

9 Years

Experience :

 Good

Maximum Limit Dealt :

Not Divulged

Remark :

Not Divulged

 

Name of Suppliers

Contact Person and Phone No.

Abbott Healthcare Private Limited –

120, Kumaran Nagar, Seevaram 1st, Perngudi, Chennai – 600096, Tamilnadu, India

Mr. Kittu – 91-9382262207

El Shaddai Health Care Private Limited –

5, Devi Flats, 49/20, G.A. Koil Steet, Choolaimedu, Chennail – 600094, Tamilnadu, India

Mr. Newman – 91-9444334663

Haritha Enterprises –

N.No: 21, O.No.:10, Hanumar Koil Steet, T. Nagar, Chennail – 600033, Tamilnadu, India

Mr. Balaji – 91-9840039453

Intas Pharmaceuticles Limited – 67, Poes Garden, Chennai – 600033, Tamilnadu, India

Mr. Raju – 91-9840811145

Medihauxe International (Private) Limited, 40/32, Karpagambal Nagar, Near Nageshwara Rao Park, Mylapore, Chenni , Tamilnadu, India

Manjunath – 91-44-24992495

Om Shakti Medi Centre –

107/104, Anna Salai, Chennai, Tamilnadu, India

Mr. Viji – 91-9840094543

Sri Meenakshi Biotec – 343, First Floor, SP Towers, Sathy Main, Sivanadapuram, Sarawanampatti – Post, Coimbatore, India

Mr. Vijay – 91-9940498483

 

 

Customers :
  • Wholesaler, Retailers, End Users and Doctors

Reference :

Global Life Care – Trichy, India

Name of the Person :

Mr. Vinod – Proprietor

Contact No.:

91-9345121456

Since How Long Known :

5 Years

Experience :

Good

Maximum Limit Dealt :

Not Divulged

Remark :

As claimed by Mr. Vinod (Proprietor) that the subject company’s product quality is very good, they make delivery on time.

 

They are doing 85% of the sale mainly to the patients in speciality medicines.

 

Name of Customers

Contact Person and Phone No.

Janani Medical  Stores –

Chennai, Tamilnadu, India

Mr. Meganathan – 91-9884071005

El Shaddai Healthcare Private Limited –

Chennai, Tamilnadu, India

Mr. Newman – 91-9444334663

Srivari Pharma –

Chennai, Tamilnadu, India

Mr. Damu – 91-9600012605

Real Care –

Chennai, Tamilnadu, India

Ashish – 91-9391152773

Telly Pharmaceuticals Private Limited –

Chennai, Tamilnadu, India

Arun – 91-9841693344

Hospital Supplier –

Chennail, Tamilnadu, India

Babu – 91-9080940002

Mercury Medicare –

Chennai, Tamilnadu, India

Rakesh – 91-9840022249

Shruthi Biotech –

Chennai, Tamilnadu, India

Rajesh – 91-9003809919

Madras Medical Mission –

Chennai, Tamilnadu, India

Durairaj – 91-7299075060

Haritha Enterprises –

Chennai, Tamilnadu, India

Balaji – 91-9840039453

 

 

No. of Employees :

5 (Approximately)

 

 

Bankers :

Banker Name

Indian Overseas Bank

Branch Address

222, Choolaimedu, Chennai – 600094, Tamilnadu, India

Person Name (With Designation)

S. Ganesh

Contact Number

91-44-24800986

Name of Account Holder

Neospan Pharma Care Private Limited

Account Number

130802000002351

Account Since (Date/Year of Account Opening)

17.07.2008

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Rs. 0.315 Million

IFS Code :

IOBA0001308

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

Banker Name

HDFC Bank Limited

Branch Address

128, Nelson Manickam Road, Branch, Aminjikarai, Chennai – 600094, Tamilnadu, India

Person Name (With Designation)

Ramesh Ganesan

Contact Number

91-9360380510

Name of Account Holder

Neospan Pharma Care Private Limited

Account Number

50200007097647

Account Since (Date/Year of Account Opening)

13.08.2014

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Cash Credit Rs. 1.440 Million

IFS Code :

HDFC0000441

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

Auditors :

 

Name :

S. Ravi and Associates

Chartered Accountant

Address :

Flat No. 2, 2nd Floor, “Kamalini”, Old  No. 16, New No. 31, CIT Colony, 1st Main Road, Mylapore, Chennai – 600004, Tamilnadu, India

Tel. No.:

91-44-24991120/2499/2848

Mob. No.:

91-9940080033 (Mr. J Chandramouli)

E-Mail :

sravica@hotmail.com

info@sravica.com

chandramouli.jc@gmail.com

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associates/Subsidiaries :

Not Available

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

Rs.10/- each

Rs. 0.100 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

Rs.10/- each

Rs. 0.100 Million

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.100

0.100

0.100

(b) Reserves & Surplus

0.040

(0.019)

(0.067)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

0.140

0.081

0.033

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.889

0.740

1.396

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.889

0.740

1.396

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.988

0.000

0.000

(b) Trade payables

1.465

0.577

1.010

(c) Other current liabilities

0.149

0.110

0.162

(d) Short-term provisions

0.044

0.005

0.020

Total Current Liabilities (4)

2.646

0.692

1.192

 

 

 

 

TOTAL

3.675

1.513

2.621

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

0.201

0.210

0.315

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.075

0.061

0.066

(e) Other Non-current assets

0.041

0.041

0.016

Total Non-Current Assets

0.317

0.312

0.397

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

2.810

0.719

0.999

(c) Trade receivables

0.477

0.333

0.670

(d) Cash and cash equivalents

0.040

0.129

0.518

(e) Short-term loans and advances

0.031

0.020

0.037

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

3.358

1.201

2.224

 

 

 

 

TOTAL

3.675

1.513

2.621

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

 

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Income

17.496

11.599

15.785

 

 

Other Income

0.018

0.010

0.015

 

 

TOTAL                                    

17.514

11.609

15.800

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchases of Stock-in-Trade

17.574

9.788

12.900

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(2.091)

0.280

0.239

 

 

Employees benefits expense

1.202

0.990

1.939

 

 

Other expenses

0.446

0.450

0.554

 

 

TOTAL                                    

17.131

11.508

15.632

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

0.383

0.101

0.168

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

0.154

0.007

0.021

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

0.229

0.094

0.147

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

0.129

0.065

0.110

 

 

 

 

 

 

PROFIT BEFORE TAX

0.100

0.029

0.037

 

 

 

 

 

Less

TAX                                                                 

0.031

0.010

0.012

 

 

 

 

 

 

PROFIT AFTER TAX

0.069

0.019

0.025

 

 

 

 

 

 

Earnings Per Share (Rs.)

6.98

1.96

2.59

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

 

31.03.2014

31.03.2013

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flow from (used in) operation

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

 

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

0.39

0.16

0.16

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

2.19

0.87

1.06

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.72

1.92

1.41

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.71

0.36

1.12

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

13.41

9.14

42.30

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.27

1.74

1.87

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

0.100

0.100

0.100

Reserves & Surplus

(0.067)

(0.019)

0.040

Share Application money pending allotment

0.000

0.000

0.000

Net worth

0.033

0.081

0.140

 

 

 

 

long-term borrowings

1.396

0.740

0.889

Short term borrowings

0.000

0.000

0.988

Current Maturities of Long Term Debt

0.000

0.000

0.000

Total borrowings

1.396

0.740

1.877

Debt/Equity ratio

42.303

9.136

13.407

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

15.785

11.599

17.496

 

 

(26.519)

50.841

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

15.785

11.599

17.496

Profit

0.025

0.019

0.069

 

0.16%

0.16%

0.39%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

----

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

No

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

Yes

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

-----

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

-----

33

Market information

-----

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

COMPUTATION OF TOTAL INCOME

 

ASSESSMENT YEAR 2015-2016

 

Particulars

 

Rs. In Million

Computation of Income under normal Provision of IT

 

Net Profit as per Profit and Loss Account

0.101

Add: Depreciation as per Companies Act, 2013

0.128

 

0.229

Less: Depreciation as per Income – Tax Rules 1962

0.086

TOTAL INCOME FOR INCOME TAX

0.142

 

0.142

A COMPUTATION OF TAX UNDER NORMAL PROVISIONS

 

TAX PARTICULARS

 

Tax on the Above Income

0.043

Add: Education Cess @ 3%

0.001

 

0.044

B COMPUTATION OF TAX UNDER 115JB

 

Net Profit after taxation as per Profit and Loss Account

0.069

Add: Current tax

0.044

Add: Deferred tax liability

(0.012)

Net Profit as per Profit and Loss Account

0.100

 

 

Add: Positive Adjustments

 

Depreciation as per companies act 2013

0.128

 

0.229

Less: Negative Adjustments

 

Depreciation as per companies act 2013

0.128

BOOK PROFIT AS PER 115JB

0.100

 

 

Tax on  the Book Profit @18%

0.018

Add: Education cess@3%

0.001

Tax payable under 115JB

0.019

 

 

C Tax payable as per A or B whichever is higher

0.044

Less: Advance tax paid

0.020

Tax Payable

0.024

 

 

 

 

PROJECTED BALANCE SHEET

 

(Rs. In Million)

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

0.100

0.100

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

1.822

0.601

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

1.922

0.701

LOAN FUNDS

 

 

 

1] Secured Loans

 

2.000

2.000

2] Unsecured Loans

 

0.475

0.718

TOTAL BORROWING

 

2.475

2.718

DEFERRED TAX LIABILITIES

 

0.000

0.000

 

 

 

 

TOTAL

 

4.397

3.419

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

0.086

0.129

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

0.000

0.000

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories
 
4.466
2.900

 

Sundry Debtors
 
2.500
1.667

 

Cash & Bank Balances
 
0.381
0.252

 

Other Current Assets
 
0.000
0.000

 

Loans & Advances
 
0.201
0.201

Total Current Assets
 
7.548
5.020

Less : CURRENT LIABILITIES & PROVISIONS
 
 
 

 

Sundry Creditors
 
2.937
1.430

 

Other Current Liabilities
 
0.300
0.300

 

Provisions
 
0.000
0.000

Total Current Liabilities
 
3.237
1.730

Net Current Assets
 
4.311
3.290

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

4.397

3.419

 

 

PROJECTED PROFT AND LOSS

 

(Rs. In Million)

 

PARTICULARS

 

31.03.2017

 

31.03.2016

 

SALES

 

 

 

 

 

Income

 

60.000

40.000

 

 

Other Income

 

0.073

0.036

 

 

TOTAL                                    

 

60.073

40.036

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of goods sold

 

52.033

34.709

 

 

Salaries and wages

 

1.500

0.893

 

 

Salaries to Directors

 

2.400

2.100

 

 

Professional and Consultancy charge

 

0.060

0.028

 

 

Staff welfare

 

0.150

0.096

 

 

Rent

 

0.300

0.213

 

 

Printing and stationery

 

0.045

0.030

 

 

Conveyance

 

0.240

0.120

 

 

Courier and postage

 

0.054

0.036

 

 

Freight and vehicle maintenance

 

0.360

0.240

 

 

Electricity charges

 

0.108

0.072

 

 

Telephone charges

 

0.090

0.060

 

 

Interest on OD @ 14%

 

0.280

0.280

 

 

Interest on Business loan

 

0.101

0.137

 

 

Insurance

 

0.024

0.012

 

 

Office expenses

 

0.180

0.096

 

 

Commission

 

0.240

0.060

 

 

Audit fees

 

0.075

0.050

 

 

Other expenses

 

0.048

0.024

 

 

TOTAL                                    

 

58.288

39.256

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

 

1.785

0.780

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

 

0.045

0.069

 

 

 

 

 

 

PROFIT BEFORE TAX

 

1.740

0.711

 

 

 

 

 

Less

TAX                                                                 

 

0.520

0.151

 

 

 

 

 

 

PROFIT AFTER TAX

 

1.220

0.560

 

 

 

PROJECT FIGURES FOR NEXT 2 YEARS

 

Particulars

2016-2017

2015-2016

Projected Purchase

69.000

34.800

Projected Sales

80.000

40.000

Expected Expenses

(Including Salaries to Staff, Finance Cost, Depreciation, Mis Expenses, Taxes etc.)

5.500

3.000

EXPECTED GROSS PROFIT

5.500

2.200

 

 

S. No.

Particulars

2017

2016

1

Sales Turnover

60.000

40.000

2

Purchase

53.600

34.800

3

Opening Stock

2.900

2.809

4

Gross profit/(Loss) (1-2)

7.966

5.290

5

Net Profit/ (Loss) before tax

1.220

0.560

6

Closing Stock

4.466

2.900

 

Ratios:

 

 

a.

Gross Profit Ratio (4/1)

13.28%

13.23%

b.

Net Profit Ratio (5/1)

2.03%

1.40%

c.

Stock-in-trade Turnover Ratio (6/1)

7.44%

7.25%

 

 

 

 

 

INTRODUCTION

 

COMPANY HISTORY

 

They started this concern as a partnership firm in 2004, in the name of Span Pharma with 2 partners. In 2008, it is been reconstituted as Neospan Pharmacare Private Limited with 4 Director. Year by year the company grown by God’s grace. In June 2013, 2 of the directors went resigned, so at present Neospan Pharma Care Private Limited with only 2 directors.

 

 

ACTIVITIES

 

Neospan Pharmcare Private Limited is a Specialty Pharma Distributor in Chennai, distributing specialty medicines, especially for the treatment of Cancer and kidney. For Chennai customers they are supplying personally through our staffs, and other part of the country through courier services.

 

 

STRATEGY : BUSINESS GOALS AND OBJECTIVES

 

At present they are only a Pharma Distributor, their objective is to market various specialty products in India

 

 

ECONOMIC INTENT

 

As like any business organization Neospan Pharma Care Private Limited also profit oriented company, but they also consider the long term patients and serving them with minimum profit.

 

 

MANAGEMENT AND OWNERSHIP

 

Neospan Pharma Care Private Limited is running with only 2 directors namely Antony Charles S F & S. Neola Jancy with equal share, and both are working in the office of Neospan. Antony Charles taking care of marketing and financial matters of the office.

 

 

ADVISORS

 

S. Ravi Associates, their auditors taking care of auditing and filing procedures and time to time advising the company matters and changes.

 

Thank you for taking the time to go through this business profile. If there are any questions or comments, please feel free to contact us.

 

 

DIRECTOR’S PROFILE

 

PROFILE OF ANTONY CHARLES S.F.

 

 

 

PROFILE OF S. NEOLA JANCY

 

 

 

NET WORTH STATEMENT

 

DETAILS OF ASSETS AND LIABILITIES OF MRS.  NEOLA JANCY ARE AS FOLLOWS:

 

Particulars

 

Rs. In Million

Rs. In Million

A. Assets

 

 

1. Investments

 

 

a) Share Capital in Neospan Pharma Care Private Limited

 

0.050

b) Director Remuneration receivable

 

0.022

2. 50% share of Market value of Property at Plot No.V, Moorthy Nagar, 3rd Street, Chettiar Agaram, Chennai – 600077 co-owned equally with husband

 

 

(Land area  1995 sq.ft. and Building 1900 sq.ft. value of Land and Building is estimated @5250 per sq.ft.)

 

5.236

3. Other Assets

 

 

a) Jewellery (60 sovereigns @2750/=)

 

1.320

b) Fixed Deposits

 

 

-       HDFC Bank

0.800

 

-       Indian Overseas Bank

0.100

0.900

Total of Assets

 

7.529

 

 

 

B. Liabilities

 

 

Housing loans with HDFC Bank (50% share of Rs. 0.603)

 

0.301

Total of Liabilities

 

0.301

NET WORTH (A-B)

 

7.227

 

 

 

 

 

DETAILS OF ASSETS AND LIABILITIES OF MR. ANTONY CHARLES SILUVAI FRANCIS ARE AS FOLLOWS:

 

Particulars

 

Rs. In Million

Rs. In Million

A. Assets

 

 

1. Investments

 

 

a) Share Capital in Neospan Pharma Care Private Limited

 

0.050

b) Director Remuneration receivable

 

0.022

2. 50% share of Market value of Property at Plot No.V, Moorthy Nagar, 3rd Street, Chettiar Agaram, Chennai – 600077 co-owned equally with husband

 

 

(Land area  1995 sq.ft. and Building 1900 sq.ft. value of Land and Building is estimated @5250 per sq.ft.)

 

5.236

3. Other Assets

 

 

a) Bank Balances as on 07.07.2015

 

 

-       HDFC Bank

 

 

b) Fixed Deposits

 

 

-       HDFC Bank

0.800

 

-       Indian Overseas Bank

0.250

1.050

Total of Assets

 

6.532

 

 

 

B. Liabilities

 

 

Housing loans with HDFC Bank (50% share of Rs. 0.603)

 

0.301

Total of Liabilities

 

0.301

NET WORTH (A-B)

 

6.231

 

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 
Unit

Indian Rupees

US Dollar

1

Rs. 63.37

UK Pound

1

Rs. 97.65

Euro

1

Rs. 70.43

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

KAS

 

 

Report Prepared by :

JYO

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILITY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

--

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.